 Merck introduced the second member of the TCA family, amitriptyline (Elavil), in 1961.This compound has a different three-ring structure than imipramine.The TCAs are used primarily in the clinical treatment of mood disorders such as major depressive disorder (MDD), dysthymia, and treatment-resistant variants.